What is Nucelis?
Nucelis operates within the precision gene editing sector, leveraging its proprietary Rapid Trait Development System (RTDS) to drive innovation in the food and agriculture industries. The company is dedicated to developing non-transgenic plant traits that enhance agricultural productivity and sustainability. By enabling farmers to achieve higher yields with reduced chemical inputs, Nucelis aims to supply sustainable ingredients to major corporations, thereby displacing fossil fuel-based components and contributing to a reduction in greenhouse gas emissions. Their advanced technology heralds a new era in plant breeding, ensuring that gene-edited traits are virtually indistinguishable from those developed through conventional methods.
How much funding has Nucelis raised?
Nucelis has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Nucelis?
The substantial capital infusion, particularly the recent strategic investment, positions Nucelis for accelerated growth and market penetration. This late-stage funding likely supports the expansion of its R&D capabilities, the scaling of its production facilities, and the strengthening of its market presence. Nucelis's focus on sustainable agricultural solutions aligns with growing global demand for environmentally conscious food production, suggesting a strong trajectory for future development and potential industry leadership.
See full Nucelis company page
